What is tomy's?
"tomy's" (Teva's Orphan hematological Malignancies award for Young hematologistS and researchers) is an educational award program for young hematologists/researchers, organized by Teva Oncology.
Each year, the tomy's program will recognize young hematologists/researchers who can illustrate the latest scientific advances in the management of orphan hematological malignancies by presenting their research in a didactic and engaging manner, demonstrating their excellence in education and presentation skills.
The first award was presented during a Teva-organized symposium at ACUTE LEUKEMIAS XVI in Munich, Germany, in February 2017.
The final presentations for the second tomy's award will take place during a Teva-organized session at the 7th International Symposium on Acute Promyelocytic Leukemia, which will be held in Rome, Italy, from September 24 to 27, 2017.
Why is Teva Oncology sponsoring this initiative?
Teva Oncology is committed to encouraging young hematologists/researchers in the study of orphan hematological malignancies, and to working together towards the goal of understanding the pathophysiology and improving diagnosis and management of these rare hematological cancers.
Who can participate in the tomy's program?
The first author should be a young hematologist/researcher, a physician training to become a hematologist, a PhD student or a PhD-level scientist; they should be aged 40 years or younger at the deadline for abstract submission.
Eligibility includes first authors affiliated to an institution in any country except the USA.
What will the tomy's winner receive?
The authors of the best abstracts (a maximum of 8) will be awarded travel and accommodation costs and registration fees to attend a European hematological congress; for the second tomy's award program this will be the 7th International Symposium on Acute Promyelocytic Leukemia in Rome, Italy, from September 24 to 27, 2017.
The authors of the top 4 abstracts will receive editorial support to develop an oral presentation to be given at a Teva-organized session during the main symposium.
The best presenter, judged both on content and presentation skills, will be chosen as the tomy's winner; he or she will be awarded the tomy's trophy, as well as travel and accommodation costs and registration fees for the American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, GA, USA, in December 2017.
The authors of the 4 next best abstracts will receive editorial, typesetting, and printing support to develop a poster to be presented at the main symposium.